Table of Content

1 Immunostimulatory Adjuvants Market Overview
1.1 Product Overview and Scope of Immunostimulatory Adjuvants
1.2 Immunostimulatory Adjuvants Segment by Type
1.2.1 Global Immunostimulatory Adjuvants Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Aluminum Hydroxide Adjuvant
1.2.3 Alum Adjuvant
1.2.4 Liposomes
1.2.5 Others
1.3 Immunostimulatory Adjuvants Segment by Application
1.3.1 Immunostimulatory Adjuvants Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Global Immunostimulatory Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Immunostimulatory Adjuvants Revenue 2016-2027
1.4.2 Global Immunostimulatory Adjuvants Sales 2016-2027
1.4.3 Immunostimulatory Adjuvants Market Size by Region: 2016 Versus 2021 Versus 2027

2 Immunostimulatory Adjuvants Market Competition by Manufacturers
2.1 Global Immunostimulatory Adjuvants Sales Market Share by Manufacturers (2016-2021)
2.2 Global Immunostimulatory Adjuvants Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Immunostimulatory Adjuvants Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Immunostimulatory Adjuvants Manufacturing Sites, Area Served, Product Type
2.5 Immunostimulatory Adjuvants Market Competitive Situation and Trends
2.5.1 Immunostimulatory Adjuvants Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Immunostimulatory Adjuvants Players Market Share by Revenue
2.5.3 Global Immunostimulatory Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Immunostimulatory Adjuvants Retrospective Market Scenario by Region
3.1 Global Immunostimulatory Adjuvants Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Immunostimulatory Adjuvants Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Immunostimulatory Adjuvants Market Facts & Figures by Country
3.3.1 North America Immunostimulatory Adjuvants Sales by Country
3.3.2 North America Immunostimulatory Adjuvants Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Immunostimulatory Adjuvants Market Facts & Figures by Country
3.4.1 Europe Immunostimulatory Adjuvants Sales by Country
3.4.2 Europe Immunostimulatory Adjuvants Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Immunostimulatory Adjuvants Market Facts & Figures by Region
3.5.1 Asia Pacific Immunostimulatory Adjuvants Sales by Region
3.5.2 Asia Pacific Immunostimulatory Adjuvants Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Immunostimulatory Adjuvants Market Facts & Figures by Country
3.6.1 Latin America Immunostimulatory Adjuvants Sales by Country
3.6.2 Latin America Immunostimulatory Adjuvants Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Immunostimulatory Adjuvants Market Facts & Figures by Country
3.7.1 Middle East and Africa Immunostimulatory Adjuvants Sales by Country
3.7.2 Middle East and Africa Immunostimulatory Adjuvants Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Immunostimulatory Adjuvants Historic Market Analysis by Type
4.1 Global Immunostimulatory Adjuvants Sales Market Share by Type (2016-2021)
4.2 Global Immunostimulatory Adjuvants Revenue Market Share by Type (2016-2021)
4.3 Global Immunostimulatory Adjuvants Price by Type (2016-2021)

5 Global Immunostimulatory Adjuvants Historic Market Analysis by Application
5.1 Global Immunostimulatory Adjuvants Sales Market Share by Application (2016-2021)
5.2 Global Immunostimulatory Adjuvants Revenue Market Share by Application (2016-2021)
5.3 Global Immunostimulatory Adjuvants Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bayer Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Adjuvance Technologies
6.2.1 Adjuvance Technologies Corporation Information
6.2.2 Adjuvance Technologies Description and Business Overview
6.2.3 Adjuvance Technologies Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Adjuvance Technologies Product Portfolio
6.2.5 Adjuvance Technologies Recent Developments/Updates
6.3 Vical
6.3.1 Vical Corporation Information
6.3.2 Vical Description and Business Overview
6.3.3 Vical Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Vical Product Portfolio
6.3.5 Vical Recent Developments/Updates
6.4 Allergy Therapeutics
6.4.1 Allergy Therapeutics Corporation Information
6.4.2 Allergy Therapeutics Description and Business Overview
6.4.3 Allergy Therapeutics Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Allergy Therapeutics Product Portfolio
6.4.5 Allergy Therapeutics Recent Developments/Updates
6.5 BioCentury
6.5.1 BioCentury Corporation Information
6.5.2 BioCentury Description and Business Overview
6.5.3 BioCentury Immunostimulatory Adjuvants Sales, Revenue and Gross Margin (2016-2021)
6.5.4 BioCentury Product Portfolio
6.5.5 BioCentury Recent Developments/Updates

7 Immunostimulatory Adjuvants Manufacturing Cost Analysis
7.1 Immunostimulatory Adjuvants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Immunostimulatory Adjuvants
7.4 Immunostimulatory Adjuvants Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Immunostimulatory Adjuvants Distributors List
8.3 Immunostimulatory Adjuvants Customers

9 Immunostimulatory Adjuvants Market Dynamics
9.1 Immunostimulatory Adjuvants Industry Trends
9.2 Immunostimulatory Adjuvants Growth Drivers
9.3 Immunostimulatory Adjuvants Market Challenges
9.4 Immunostimulatory Adjuvants Market Restraints

10 Global Market Forecast
10.1 Immunostimulatory Adjuvants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Immunostimulatory Adjuvants by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Immunostimulatory Adjuvants by Type (2022-2027)
10.2 Immunostimulatory Adjuvants Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Immunostimulatory Adjuvants by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Immunostimulatory Adjuvants by Application (2022-2027)
10.3 Immunostimulatory Adjuvants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Immunostimulatory Adjuvants by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Immunostimulatory Adjuvants by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Immunostimulatory Adjuvants Sales (K Pieces) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Immunostimulatory Adjuvants Sales (K Pieces) Comparison by Application (2021-2027)
Table 3. Global Immunostimulatory Adjuvants Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Immunostimulatory Adjuvants Covered in This Study
Table 5. Global Immunostimulatory Adjuvants Sales (K Pieces) of Key Manufacturers (2016-2021)
Table 6. Global Immunostimulatory Adjuvants Sales Share by Manufacturers (2016-2021)
Table 7. Global Immunostimulatory Adjuvants Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Immunostimulatory Adjuvants Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Immunostimulatory Adjuvants Average Price (USD/Piece) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Immunostimulatory Adjuvants Manufacturing Sites and Area Served
Table 11. Manufacturers Immunostimulatory Adjuvants Product Type
Table 12. Global Immunostimulatory Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Immunostimulatory Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunostimulatory Adjuvants as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Immunostimulatory Adjuvants Sales by Region (2016-2021) & (K Pieces)
Table 16. Global Immunostimulatory Adjuvants Sales Market Share by Region (2016-2021)
Table 17. Global Immunostimulatory Adjuvants Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Immunostimulatory Adjuvants Sales by Country (2016-2021) & (K Pieces)
Table 19. North America Immunostimulatory Adjuvants Sales Market Share by Country (2016-2021)
Table 20. North America Immunostimulatory Adjuvants Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Immunostimulatory Adjuvants Revenue Market Share by Country (2016-2021)
Table 22. Europe Immunostimulatory Adjuvants Sales by Country (2016-2021) & (K Pieces)
Table 23. Europe Immunostimulatory Adjuvants Sales Market Share by Country (2016-2021)
Table 24. Europe Immunostimulatory Adjuvants Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Immunostimulatory Adjuvants Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Immunostimulatory Adjuvants Sales by Region (2016-2021) & (K Pieces)
Table 27. Asia Pacific Immunostimulatory Adjuvants Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Immunostimulatory Adjuvants Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Immunostimulatory Adjuvants Revenue Market Share by Region (2016-2021)
Table 30. Latin America Immunostimulatory Adjuvants Sales by Country (2016-2021) & (K Pieces)
Table 31. Latin America Immunostimulatory Adjuvants Sales Market Share by Country (2016-2021)
Table 32. Latin America Immunostimulatory Adjuvants Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Immunostimulatory Adjuvants Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Immunostimulatory Adjuvants Sales by Country (2016-2021) & (K Pieces)
Table 35. Middle East and Africa Immunostimulatory Adjuvants Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Immunostimulatory Adjuvants Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Immunostimulatory Adjuvants Revenue Market Share by Country (2016-2021)
Table 38. Global Immunostimulatory Adjuvants Sales (K Pieces) by Type (2016-2021)
Table 39. Global Immunostimulatory Adjuvants Sales Market Share by Type (2016-2021)
Table 40. Global Immunostimulatory Adjuvants Revenue (Million US$) by Type (2016-2021)
Table 41. Global Immunostimulatory Adjuvants Revenue Share by Type (2016-2021)
Table 42. Global Immunostimulatory Adjuvants Price (USD/Piece) by Type (2016-2021)
Table 43. Global Immunostimulatory Adjuvants Sales (K Pieces) by Application (2016-2021)
Table 44. Global Immunostimulatory Adjuvants Sales Market Share by Application (2016-2021)
Table 45. Global Immunostimulatory Adjuvants Revenue (Million US$) by Application (2016-2021)
Table 46. Global Immunostimulatory Adjuvants Revenue Share by Application (2016-2021)
Table 47. Global Immunostimulatory Adjuvants Price (USD/Piece) by Application (2016-2021)
Table 48. Bayer Corporation Information
Table 49. Bayer Description and Business Overview
Table 50. Bayer Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 51. Bayer Immunostimulatory Adjuvants Product
Table 52. Bayer Recent Developments/Updates
Table 53. Adjuvance Technologies Corporation Information
Table 54. Adjuvance Technologies Description and Business Overview
Table 55. Adjuvance Technologies Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 56. Adjuvance Technologies Immunostimulatory Adjuvants Product
Table 57. Adjuvance Technologies Recent Developments/Updates
Table 58. Vical Corporation Information
Table 59. Vical Description and Business Overview
Table 60. Vical Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 61. Vical Immunostimulatory Adjuvants Product
Table 62. Vical Recent Developments/Updates
Table 63. Allergy Therapeutics Corporation Information
Table 64. Allergy Therapeutics Description and Business Overview
Table 65. Allergy Therapeutics Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 66. Allergy Therapeutics Immunostimulatory Adjuvants Product
Table 67. Allergy Therapeutics Recent Developments/Updates
Table 68. BioCentury Corporation Information
Table 69. BioCentury Description and Business Overview
Table 70. BioCentury Immunostimulatory Adjuvants Sales (K Pieces), Revenue (Million US$), Price (USD/Piece) and Gross Margin (2016-2021)
Table 71. BioCentury Immunostimulatory Adjuvants Product
Table 72. BioCentury Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Immunostimulatory Adjuvants Distributors List
Table 76. Immunostimulatory Adjuvants Customers List
Table 77. Immunostimulatory Adjuvants Market Trends
Table 78. Immunostimulatory Adjuvants Growth Drivers
Table 79. Immunostimulatory Adjuvants Market Restraints
Table 80. Global Immunostimulatory Adjuvants Sales Forecast by Type (2022-2027) & (K Pieces)
Table 81. Global Immunostimulatory Adjuvants Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Immunostimulatory Adjuvants Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Immunostimulatory Adjuvants Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Immunostimulatory Adjuvants Sales Forecast by Application (2022-2027) & (K Pieces)
Table 85. Global Immunostimulatory Adjuvants Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Immunostimulatory Adjuvants Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Immunostimulatory Adjuvants Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Immunostimulatory Adjuvants Sales Forecast by Region (2022-2027) & (K Pieces)
Table 89. Global Immunostimulatory Adjuvants Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Immunostimulatory Adjuvants Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Immunostimulatory Adjuvants Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Immunostimulatory Adjuvants
Figure 2. Global Immunostimulatory Adjuvants Market Share by Type in 2020 & 2027
Figure 3. Aluminum Hydroxide Adjuvant Product Picture
Figure 4. Alum Adjuvant Product Picture
Figure 5. Liposomes Product Picture
Figure 6. Others Product Picture
Figure 7. Global Immunostimulatory Adjuvants Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Medical Centers
Figure 10. Others
Figure 11. Global Immunostimulatory Adjuvants Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Immunostimulatory Adjuvants Market Size 2016-2027 (US$ Million)
Figure 13. Global Immunostimulatory Adjuvants Sales 2016-2027 (K Pieces)
Figure 14. Global Immunostimulatory Adjuvants Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Immunostimulatory Adjuvants Sales Share by Manufacturers in 2020
Figure 16. Global Immunostimulatory Adjuvants Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Immunostimulatory Adjuvants Players: Market Share by Revenue in 2020
Figure 18. Immunostimulatory Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Immunostimulatory Adjuvants Sales Market Share by Region (2016-2021)
Figure 20. Global Immunostimulatory Adjuvants Sales Market Share by Region in 2020
Figure 21. Global Immunostimulatory Adjuvants Revenue Market Share by Region (2016-2021)
Figure 22. Global Immunostimulatory Adjuvants Revenue Market Share by Region in 2020
Figure 23. U.S. Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Immunostimulatory Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Immunostimulatory Adjuvants by Type (2016-2021)
Figure 48. Sales Market Share of Immunostimulatory Adjuvants by Application (2016-2021)
Figure 49. Sales Market Share of Immunostimulatory Adjuvants by Application in 2020
Figure 50. Revenue Share of Immunostimulatory Adjuvants by Application (2016-2021)
Figure 51. Revenue Share of Immunostimulatory Adjuvants by Application in 2020
Figure 52. Manufacturing Cost Structure of Immunostimulatory Adjuvants
Figure 53. Manufacturing Process Analysis of Immunostimulatory Adjuvants
Figure 54. Immunostimulatory Adjuvants Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed